Page 59 - Query Get News Today

Between 11% and 17% of patients with chronic kidney disease developed chronic hyperkalemia, which was more consistently associated with death than with major adverse cardiovascular events, findings from an observational study showed.For the study, investigators from Sweden included 36,511 patients with CKD stages G3 through G5 and examined the trajectories of abnormal potassium levels to assess

A 55-year-old white man presented with the complaint of sudden onset central scotoma in both eyes for 1 month. The patient reported the condition slightly improved from the initial onset. His medical history was positive for syphilis, HIV, hyperlipidemia and anxiety. The patient reported that he was a former smoker, social drinker and used recreational drugs. His ocular history was unremarkable.

Vulnerable subgroups of veterans had increased risk for cannabis use disorder and nonmedical use, according to results of a survey study published in American Journal of Psychiatry.“Given growing legalization and acceptability of cannabis use, nationally representative data are needed to understand cannabis use among veterans, including frequent use patterns (eg, daily use) and cannabis use

Patients with PTSD demonstrated a two-fold higher likelihood of being diagnosed with systemic lupus erythematosus, compared to those without PTSD, according to data published in Arthritis Care & Research. “Traumatic events, such as combat and sexual assault, have been linked to changes in the immune system, and cohort studies have found higher rates of a variety of autoimmune diseases

Zimmer Biomet Holdings Inc. reported net sales of $2.027 billion for the second quarter of 2021, according to reported financial results. The second-quarter net sales showed a 65.3% increase from the prior year period and a 60.7% increase on a constant currency basis. Additionally, second-quarter 2021 sales increased 1.9% compared with the second quarter in 2019, before the COVID-19 pandemic.

Pembrolizumab plus gemcitabine, vinorelbine and liposomal doxorubicin demonstrated substantial efficacy as second-line therapy among patients with relapsed or refractory classical Hodgkin lymphoma, according to phase 2 study results.The findings, published in Journal of Clinical Oncology, also showed the combination had a favorable toxicity profile.

A third dose of the Moderna COVID-19 vaccine substantially improved protection for transplant recipients, according to findings published in the New England Journal of Medicine.The data are from the first-ever randomized, placebo-controlled trial of a COVID-19 vaccine booster dose in transplant recipients, according to a press release.

Expert offers pearls for matching patients with the right IOL Source: Auffarth GU. Pearls for choosing the right IOL for the right patient. Presented at: American Society of Cataract and Refractive Surgery meeting; July 23-27, 2021; Las Vegas. Disclosures: Auffarth reports relevant financial disclosures for AcuFocus, Alcon, Alimera, Anew, Bausch + Lomb, Biotech, Carl Zeiss Meditec, Contamac, Glaukos, Hoya, Johnson & Johnson, Kowa, Oculentis/Teleon, Oculus, PhysIOL, Presbia, Rayner, Santen, ...

Few adolescents report speaking with their doctors about sexual health ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS Youve successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact cus...

Improving Compliance Through Sustained-release Delivery Systems for Glaucoma Management Exploring the Need for New Treatment Options in the Management of Glaucoma Sustained-release Delvery of Glaucoma Treatment: Comparing New and Emerging Options Glaucoma Drug Delivery Case Presentations Educational Tools Exploring the Need for New Treatment Options in the Management of Glaucoma Sustained-release Delvery of Glaucoma Treatment: Comparing New and Emerging Options Glaucoma Drug Delivery Case Pre...